COMMUNIQUÉS West-GlobeNewswire

-
Innovation Pharmaceuticals Files Form 10-Q Quarterly Report
11/02/2019 -
Biohit Oyj: Managers' Transactions
11/02/2019 -
Novo Nordisk A/S - Share repurchase programme
11/02/2019 -
RESTORE Consortium, of which Pluristem is a member, Nominated to Be One of Two Finalists Competing for a Potential Award for Development of Advanced Therapeutics
11/02/2019 -
Tabula Rasa Healthcare to Announce Fourth Quarter and Full Year 2018 Operating Results and Host Conference Call on Thursday, February 28, 2019
11/02/2019 -
Exagen Inc. to Present at the Cowen and Company 39th Annual Health Care Conference 2019
11/02/2019 -
Diamond CBD Takes Center Stage at Tobacco Plus Expo in Las Vegas
11/02/2019 -
Orion and Propeller Health partner to bring new digital medicines to people with asthma and COPD
11/02/2019 -
NRC Health Partners with Premier Senior-living Podcast
11/02/2019 -
Indiva’s Ontario Cannabis Store Supply Agreement a Testament to Quality -- CFN Media
11/02/2019 -
Alphatec Announces Stay of Court Proceedings in NuVasive Patent Lawsuit
11/02/2019 -
Cerner Leverages AI Solutions to Combat Physician Burnout
11/02/2019 -
Alkaline88: A Well Known Brand with Unmatched Distribution Targets CBD Beverages -- CFN Media
11/02/2019 -
Imprivata Partners with Google Cloud to Enable Single Sign-On Access to Chrome Devices
11/02/2019 -
CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors
11/02/2019 -
Driven Deliveries Inc. Expands California Cannabis Delivery Platform
11/02/2019 -
Eve & Co Announces Retail Release of Dried Flower
11/02/2019 -
Yield Growth Expanding Product Lines & Distribution Footprint-- CFN Media
11/02/2019 -
Hemispherx Biopharma Announces Commencement of a New 45 Subject Clinical Trial Combining Ampligen and Merck’s Keytruda in the Treatment of Recurrent Ovarian Cancer
11/02/2019
Pages